# Clinical Validation of an On-Device AI-Driven Real-Time Human Pose Estimation and Exercise Prescription Program; Prospective Single-Arm Quasi-Experimental Study

**Authors:** Seoyoon Heo, Taeseok Choi, Wansuk Choi

PMC · DOI: 10.3390/healthcare14040482 · 2026-02-13

## TL;DR

A smartphone app using AI to guide resistance training improves strength and fitness in young adults without gym access.

## Contribution

First clinical validation of on-device AI for real-time exercise guidance with outcomes comparable to traditional programs.

## Key findings

- Muscular strength increased by 4.39 kg in 1RM squat after 16 weeks.
- Body fat decreased by 2.92% while skeletal muscle mass increased by 2.19 kg.
- VO2max improved by 1.82 mL/kg/min, showing enhanced cardiorespiratory fitness.

## Abstract

Background: Physical inactivity remains a major public health challenge, particularly for underserved populations lacking exercise facility access. AI-powered smartphone applications with real-time human pose estimation offer scalable solutions, but they lack rigorous clinical validation. Objective: This study validates the clinical efficacy of a 16-week on-device AI-driven resistance training program using MediaPipe pose estimation technology in young adults with limited facility access. Primary outcomes included muscular strength (1RM squat), body composition, functional movement (FMS), and cardiorespiratory fitness (VO2max). Methods: A single-group pre–post study enrolled 216 participants (mean age 23.77 ± 4.02 years; 69.2% male), with 146 (67.6%) completing the protocol. Participants performed three 30 min weekly sessions of seven compound exercises delivered via a smartphone app providing real-time pose analysis (97.2% key point accuracy, 28.6 ms inference), multimodal feedback, and personalized progression using self-selected equipment. Results: Significant improvements across all domains: muscular strength (+4.39 kg 1RM squat, p < 0.001, d = 1.148), body fat (−2.92%, p < 0.001, d = −1.373), skeletal muscle mass (+2.19 kg, p < 0.001, d = 1.433), FMS (+0.29 points, p = 0.001, d = 0.285), and VO2max (+1.82 mL/kg/min, p < 0.001, d = 0.917). Pose classification accuracy reached 95.8% vs. physiotherapist assessment (ICC = 0.94). Conclusions: This study provides the first clinical evidence that on-device AI pose estimation enables facility-independent resistance training with outcomes comparable to traditional programs. Unlike cloud-based systems, our lightweight model (28.6 ms inference) supports real-time mobile deployment, advancing accessible precision exercise medicine. Limitations include a single-arm design and gender imbalance, warranting future RCTs with diverse cohorts.

## Full-text entities

- **Diseases:** chronic disease (MESH:D002908), type 2 diabetes (MESH:D003924), adiposity (MESH:D018205), cardiovascular disease (MESH:D002318), COVID-19 (MESH:D000086382), deaths (MESH:D003643), muscle hypertrophy (MESH:C536106), Physical inactivity (MESH:C564765), AI (MESH:C538142), obesity (MESH:D009765), fatigue (MESH:D005221), accidents (MESH:D000081084), injury (MESH:D014947), pain (MESH:D010146)
- **Chemicals:** MPA (-), caffeine (MESH:D002110), Oxygen (MESH:D010100)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** RPE 15-16 — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_4388)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940220/full.md

---
Source: https://tomesphere.com/paper/PMC12940220